Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug 19:11:1788.
doi: 10.3389/fimmu.2020.01788. eCollection 2020.

MAIT Cells at the Fetal-Maternal Interface During Pregnancy

Affiliations
Review

MAIT Cells at the Fetal-Maternal Interface During Pregnancy

Helen Kaipe et al. Front Immunol. .

Abstract

One of the main functions of the human placenta is to provide a barrier between the fetal and maternal blood circulations, where gas exchange and transfer of nutrients to the developing fetus take place. Despite being a barrier, there is a multitude of crosstalk between maternal immune cells and fetally derived semi-allogeneic trophoblast cells. Therefore, the maternal immune system has a difficult task to both tolerate the fetus but at the same time also defend the mother and the fetus from infections. Mucosal-associated invariant T (MAIT) cells are an increasingly recognized subset of T cells with anti-microbial functions that get activated in the context of non-polymorphic MR1 molecules, but also in response to inflammation. MAIT cells accumulate at term pregnancy in the maternal blood that flows into the intervillous space inside the placenta. Chemotactic factors produced by the placenta may be involved in recruiting and retaining particular immune cell subsets, including MAIT cells. In this Mini-Review, we describe what is known about MAIT cells during pregnancy and discuss the potential biological functions of MAIT cells at the fetal-maternal interface. Since MAIT cells have anti-microbial and tissue-repairing functions, but lack alloantigen reactivity, they could play an important role in protecting the fetus from bacterial infections and maintaining tissue homeostasis without risks of mediating harmful responses toward semi-allogenic fetal tissues.

Keywords: MAIT cells; decidua; intervillous blood; placenta; pregnancy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Fetal-maternal interface and immune cells at term pregnancy. The placenta serves to ensure exchange of nutrients and gases between the maternal and fetal blood circulation. The fetal part of the fetal-maternal interface consists of chorionic villi that extend from the chorionic plate (A) into the intervillous space and bathe in maternal intervillous blood (B). On the maternal side, the decidua parietalis and decidua basalis are in direct contact with fetal membranes (amniochorion) and the invading fetal extravillous trophoblasts, respectively (A). The intervillous blood enters the intervillous space through spiral arteries (B) and leaves this compartment through uterine veins (not shown). Maternal immune cells in the intervillous blood are in direct contact with the fetal syncytiotrophoblast and decidual immune cells can interact with extravillous trophoblasts (B). DSC, decidual stromal cells; HC, Hofbauer cells (fetal macrophages); MAIT, mucosal associated invariant T cells; MΦ, macrophages; uNK, uterine natural killer cells. The pink cells in the intervillous space depict erythrocytes.

References

    1. Arck PC, Hecher K. Fetomaternal immune cross-talk and its consequences for maternal and offspring's health. Nat Med. (2013) 19:548–56. 10.1038/nm.3160 - DOI - PubMed
    1. Svensson-Arvelund J, Ernerudh J, Buse E, Cline JM, Haeger JD, Dixon D, et al. . The placenta in toxicology. Part II: systemic and local immune adaptations in pregnancy. Toxicol Pathol. (2014) 42:327–38. 10.1177/0192623313482205 - DOI - PubMed
    1. Lutz M, Worschech A, Alb M, Gahn S, Bernhard L, Schwab M, et al. . Boost and loss of immune responses against tumor-associated antigens in the course of pregnancy as a model for allogeneic immunotherapy. Blood. (2015) 125:261–72. 10.1182/blood-2014-09-601302 - DOI - PubMed
    1. Ariga H, Ohto H, Busch MP, Imamura S, Watson R, Reed W, et al. . Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal diagnosis. Transfusion. (2001) 41:1524–30. 10.1046/j.1537-2995.2001.41121524.x - DOI - PubMed
    1. Lee J, Romero R, Xu Y, Miranda J, Yoo W, Chaemsaithong P, et al. . Detection of anti-HLA antibodies in maternal blood in the second trimester to identify patients at risk of antibody-mediated maternal anti-fetal rejection and spontaneous preterm delivery. Am J Reprod Immunol. (2013) 70:162–75. 10.1111/aji.12141 - DOI - PMC - PubMed

Publication types

MeSH terms